Immunity of tonsil and IgA nephropathy - Relationship between IgA nephropathy and tonsillitis

Acta Oto-Laryngologica, Supplement

Volumn 124, Issue 555, 2004, Pages 6-9

  Kuki, Kiyonori ^a   Gotoh, Hironobu ^a   Hayashi, Masaki ^a   Hujihara, Keiji ^a   Tamura, Shinji ^a   Yamanaka, Noboru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokines; ELISA; IL 8; MCP 1; Tonsillar mononuclear cells

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; STAPHYLOCOCCUS ENTEROTOXIN B;

CELL ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; INFORMED CONSENT; KIDNEY BIOPSY; MESANGIUM; MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR; SUPERNATANT; TONSIL; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; ARTICLE; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; METABOLISM;

CELLS, CULTURED; CYTOKINES; GLOMERULONEPHRITIS, IGA; HUMANS; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; TONSIL; TONSILLITIS;

EID: 11144288055     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: 10.1080/03655230410003350     Document Type: Conference Paper

References (22)

1. D'amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-27.
2. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-15.
3. Donadio JV Jr, Grande JP. Immunoglobulin A nephropathy: a clinical perspective. J Am Soc Nephrol 1997; 8: 1324-32.
4. Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 2001; 38: 736-43.
5. Xie Y, Nishi S, Ueno M, Imai N, Sakatsme M, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 2003; 63: 1861-7.
6. Rasche FM, Schwarz A, Keller F. Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol 1999; 51: 147-52.
7. Bene MC, Hurault de Ligny B, Kessler M, et al. Tonsils in IgA nephropathy. Contrib Nephrol 1993; 104: 153-61.
8. Caraman PL, Azoulay E, Kessler M. et al. Mucosal infections and allergy in IgA nephropathy. A retrospective study. Contrib Nephrol 1993; 104: 24-30.
9. Schena FP, Gesualdo L, Grandaliano G. Montinaro V. Progression of renal damage in human glomerulonephritides: Is ther sleight of hand in winning the game? Kidney Int 1997; 52: 1439-57.
10. Stahl RAK. Chemoattractive cytokines (chemokines) and immune renal injury. Nephrol Dial Transplant 1995; 10: 307-9.
11. Fujieda S, Suzuki S, Sunaga H, Yamamoto H, Seki M, Sugimoto H, Saito H. Production of interferon-gamma by tonsillar mononuclear cells in IgA nephropathy patients. Acta Otolaryngol 2000; 120: 649-54.
12. Tomino Y. IgA nephropathy. From molecules to men. Contrib Nephrol 1999; 126: III-IX: 1-115.
13. Kusakari C. Nose M, Takasaka T, et al. Immunohistological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells. Clin Exp Immunol 1994; 95: 42-8.
14. Tamura S, Masuda Y, Inokuchi I, et al. Effect of and indication for tonsillectomy in IgA nephropathy. Acta Otolaryngol 1993; Suppl 508: 23-8.
15. Scivittaro V, Gesualdo L, Ranieri E, Marfella C, Schewn SA, Emancipator SN, Schena FP. Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred. Clin Exp Immunol 1944; 96: 311-6.
16. Baba Y, Akagi H, Fukushima K, Kosaka M, Hattori K, Nishizawa K, Ogawa T, Masuda Y, Shikata K. Quantitative analysis of interleukin 6 (IL-6) in patients with IgA nephropathy after tonsillectomy. Auris Nasus Larynx 1999; 26: 177-82.
17. Fujieda S, Suzuki S, Sunaga H, Yamamoto H, Seki M, Sugimoto H, Saito H. Induction of IgA against Haemophilus parainfluenzae antigens in tonsillar mononuclear cells from patients with IgA nephropathy. Clin Immunol 2000; 95: 235-43.
18. Yokoyama H, Wada T, Furiichi K, Segawa C. Shimizu M, Kobayashi K, Su S, Mukaida N, Matsushima K. Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukoc Biol 1998; 63: 493-9.
19. Grandaliano G, Gesualdo L, Ranieri E. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 1996; 7: 906-13.
20. Saitoh A, Suzuki Y, Takeda M, Kubota K, Itoh K, Tomino Y. Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy. J Clin Lab Anal 1998; 12: 1-5.
21. Lai KN, Shute JK, Lindley IJ, Lai FM, Yu AW, Li PK, Lai CK. Neutrophil attractant protein-1 interleukin 8 and its autoantibodies in IGA nephropathy. Clin Immunol Immunopathol 1996; 80: 47-54.
22. Huang F, Horikoshi S, Kurusu A, Shibata T, Suzuki S, Funabiki K, Shirato I, Tomino Y. Urinary level of interleukin-8(IL-8) and disease activity in patients with IgA nephropathy. J Clin Lab Anal 2001; 15: 30-4.